Laure Lebras

988 total citations
20 papers, 178 citations indexed

About

Laure Lebras is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Laure Lebras has authored 20 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Laure Lebras's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (3 papers). Laure Lebras is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (3 papers). Laure Lebras collaborates with scholars based in France, Belgium and Australia. Laure Lebras's co-authors include Gilles Salles, Bertrand Coiffier, Françoise Berger, Anne‐Sophie Michallet, Florence Ranchon, Franck‐Emmanuel Nicolini, Florence Ader, Lila Gilis, Xavier Thomas and Fiorenza Barraco and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and British Journal of Haematology.

In The Last Decade

Laure Lebras

18 papers receiving 173 citations

Peers

Laure Lebras
Stephanie Mathews United States
Karthik Nath Australia
Anne Lok France
Emil Kumar United Kingdom
Stephanie Mathews United States
Laure Lebras
Citations per year, relative to Laure Lebras Laure Lebras (= 1×) peers Stephanie Mathews

Countries citing papers authored by Laure Lebras

Since Specialization
Citations

This map shows the geographic impact of Laure Lebras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Lebras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Lebras more than expected).

Fields of papers citing papers by Laure Lebras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laure Lebras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Lebras. The network helps show where Laure Lebras may publish in the future.

Co-authorship network of co-authors of Laure Lebras

This figure shows the co-authorship network connecting the top 25 collaborators of Laure Lebras. A scholar is included among the top collaborators of Laure Lebras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laure Lebras. Laure Lebras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérol, Olivia, Marvin Borja, Stéphane Morisset, et al.. (2025). Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study. Frontiers in Medicine. 12. 1469930–1469930.
2.
Nicolas‐Virelizier, Emmanuelle, Chiara Russo, Olivia Pérol, et al.. (2021). Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial. BMJ Open. 11(6). e046409–e046409. 1 indexed citations
4.
Bologna, Serge, Thierry Vander Borght, Josette Brière, et al.. (2021). EARLY POSITRON EMISSION TOMOGRAPHY RESPONSE‐ADAPTED TREATMENT IN LOCALIZED DIFFUSE LARGE B‐CELL LYMPHOMA (AAIPI=0) : RESULTS OF THE PHASE 3 LYSA LNH 09‐1B TRIAL. Hematological Oncology. 39(S2). 13 indexed citations
5.
Sesques, Pierre, Jessie Bourcier, Camille Golfier, et al.. (2020). Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Hematological Oncology. 38(2). 137–145. 4 indexed citations
7.
Michallet, Mauricette, Mohamad Sobh, Emmanuelle Nicolas‐Virelizier, et al.. (2019). Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study. Blood. 134(Supplement_1). 5817–5817. 1 indexed citations
8.
Crocchiolo, Roberto, Valérie Dubois, Mohamed Sobh, et al.. (2017). Skin allograft for severe chronic GvHD. Bone Marrow Transplantation. 52(7). 1060–1062. 3 indexed citations
9.
Ranchon, Florence, Lila Gilis, Vérane Schwiertz, et al.. (2015). Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(4). 723–730. 58 indexed citations
10.
Michallet, Mauricette, Mohamad Sobh, Mohamed Elhamri, et al.. (2014). Therapeutic Management of Acute Myeloid Leukemia Patients after Stratification on Age, Prognosis and Allogeneic Hematopoietic Stem Cell Transplantation Eligibility. Blood. 124(21). 3691–3691. 1 indexed citations
11.
Michallet, Mauricette, Mohamad Sobh, Marie Y. Detrait, et al.. (2014). Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients. Blood. 124(21). 3892–3892. 1 indexed citations
12.
Brisou, Gabriel, Lionel Karlin, Laure Lebras, et al.. (2013). Pregnancy and multiple myeloma are not antinomic. Leukemia & lymphoma. 54(12). 2738–2741. 9 indexed citations
13.
Lebras, Laure, Deborah Bauwens, Françoise Berger, et al.. (2013). Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?. Journal of Hematology & Oncology. 6(1). 45–45. 28 indexed citations
14.
Sarkozy, Clémentine, Lucile Baseggio, Pierre Feugier, et al.. (2013). Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis. British Journal of Haematology. 164(5). 659–667. 24 indexed citations
15.
Bari, Berardino De, et al.. (2012). Does weight loss predict accuracy of setup in head and neck cancer patients treated with Intensity-Modulated Radiation Therapy?. La radiologia medica. 117(5). 885–891. 8 indexed citations
16.
Michallet, Anne‐Sophie, Laure Lebras, & Bertrand Coiffier. (2012). Maintenance therapy in diffuse large B-cell lymphoma. Current Opinion in Oncology. 24(5). 461–465. 5 indexed citations
17.
Sarkozy, Clémentine, Lucile Baseggio, Evelyne Callet‐Bauchu, et al.. (2012). Detection of Leukemic Phase in Patients with Follicular Lymphoma At Diagnosis: A Rare Event Associated with Poor Prognosis. Blood. 120(21). 1594–1594. 3 indexed citations
18.
Michallet, Anne‐Sophie, et al.. (2012). Early Stage Follicular Lymphoma: Is There a Clinical Impact of First Line Treatment?. Blood. 120(21). 2722–2722. 1 indexed citations
19.
Valour, Florent, Sandrine Boisset, Laure Lebras, et al.. (2010). Clostridium sordellii Brain Abscess Diagnosed by 16S rRNA Gene Sequencing. Journal of Clinical Microbiology. 48(9). 3443–3444. 10 indexed citations
20.
Lebras, Laure, D. Arpin, Sophie Collardeau‐Frachon, et al.. (2008). L’hyperplasie neuroendocrine pulmonaire idiopathique : une lésion prénéoplasique méconnue. Revue des Maladies Respiratoires. 25(9). 1131–1135. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026